As COX-2 is a potential downstream target of the PTEN/Akt pathway in cancer and has a role in inflammation, peri-nuclear tumour cell expression was assessed to investigate if COX-2 could provide a link between activation of tumour PTEN/Akt and inflammation. Here, AKT1 is linked to neoplasm.